A drug of abuse urine screen typically tests for the presence of commonly abused drugs in urine samples. These tests are often conducted in various settings, including workplaces, healthcare facilities, rehabilitation centers, and legal proceedings. A 7-drug urine screen commonly tests for the presence of the following substances:

1. Cannabis (THC): Detects marijuana, hashish, or other cannabis products. THC (tetrahydrocannabinol) is the primary psychoactive compound in cannabis.
2. Cocaine (COC): Detects cocaine, including both the parent drug and its metabolites, such as benzoylecgonine.
3. Opiates (OPI): Detects opioids, including drugs like heroin, morphine, codeine, and oxycodone. Opiates can also include synthetic opioids like fentanyl and its analogs.
4. Amphetamines (AMP): Detects drugs like amphetamine and methamphetamine, commonly used as stimulants.
5. Methamphetamines (mAMP): Specifically targets methamphetamine, a potent central nervous system stimulant.
6. Benzodiazepines (BZO): Detects drugs in the benzodiazepine class, which are commonly prescribed for anxiety, insomnia, and other conditions. Examples include diazepam (Valium), alprazolam (Xanax), and lorazepam (Ativan).
7. Barbiturates (BAR): Detects drugs in the barbiturate class, which are sedative-hypnotic medications. Barbiturates were once commonly prescribed for anxiety, insomnia, and seizures but are now less commonly used due to the availability of safer alternatives.

The 7-drug urine screen provides a comprehensive assessment of recent drug use within a specific timeframe, typically ranging from a few days to a week, depending on the substance and individual factors such as metabolism. Positive results may indicate recent drug use, but confirmation testing and clinical evaluation are often needed for definitive diagnosis and management.